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KEY POINTS
● Prior to COVID-19, teledermatology was 
limited due to limited insurance 
reimbursement for telemedicine visits, 
concern about liabilities, and licensing 
restrictions.
● COVID-19 prompted regulatory and policy 
changes, with corresponding new 
telemedicine growth and innovation; health 
systems created and adapted protocols to 
continue care, save personal protective 
equipment, and decrease unnecessary 
exposures.
● Teledermatology has been conducive to 
COVID-19 constraints, but limitations focus 
on access; dependence on telemedicine 
may actually worsen care for many patients 
who lack digital access. 
● Expansion of telemedicine reimbursements 
favored synchronous video visits rather 
than store-and-forward teledermatology, 
which may be a missed opportunity for 
more efficient delivery of care.  
● Policy changes established during 
COVID-19, though possibly temporary, 
have nevertheless set new precedents that 
will surely have long-term impacts on 
teledermatology use post-pandemic.
CONCLUSIONS
In the long-term, the success of teledermatology will be 
dependent on federal and state policies and laws, as well as 
payers. Future policy must consider telemedicine expansion 
beyond geographic restrictions and further reimbursement 
increases and utilization of SAF. For sustained growth, 
government policy makers, physicians, insurance companies, 
and patient advocacy organizations must partner to create a 
system to fortify telemedicine with the many challenges of 








Financial waivers could mitigate cost of 
devices and internet access
Interpretation 
Services
Modeled after interpretation services 
used in patient, can increase quality of 




Community based Teledermatology 
programs can serve as an adjunct to 
assist with ease of use
EXPANSION OF TELEDERMATOLOGY 
DURING COVID-19
A study of 168 patients found the most popular reasons for 
telehealth appointments to be new rash (12%), eczema 
(10%), and psoriasis (9%). A study of 153 U.S. dermatology 
practices operating during the pandemic found that 87% of 
practices offered teledermatology as an option to patients. 
Across 12 dermatology clinics affiliated with Massachusetts 
General Hospital, virtual visits rose from 0 in April 2019 to 
1,564 in April 2020, while in-person visits for April 2020 
represented less than 1% of the in-person visit volume from 
the year prior. Before March 11, 2020, when the WHO 
officially declared the COVID-19 pandemic, skin conditions 
were not listed among the most common telehealth 
diagnoses in the United States. However, by April 2020, 
skin conditions were ranked the fifth most common 
telehealth diagnosis in the U.S. Similarly, as of July 21, 
2020, 13 of the top 50 ranked medical applications in the 
U.S. Apple App Store were usable for telemedicine, an 
increase of mean of 210.92 ranked positions from January 
1, 2020.
LESSONS LEARNED DURING 
COVID-19Teledermatology’s efficacy may vary in different 
populations. The elderly may require assistance using 
digital devices. We must also consider the emerging 
American population whose first language is not English.  
Additional services could provide caregivers for the elderly 
and translators for non-English speakers to improve 
adaptation.
